These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 7116711)

  • 1. A cohort study of cervical cancer screening in British Columbia.
    Boyes DA; Morrison B; Knox EG; Draper GJ; Miller AB
    Clin Invest Med; 1982; 5(1):1-29. PubMed ID: 7116711
    [No Abstract]   [Full Text] [Related]  

  • 2. Cervical cancer screening data from two cohorts in British Columbia.
    van Oortmarssen GJ; Habbema JD
    IARC Sci Publ; 1986; (76):47-60. PubMed ID: 3570415
    [No Abstract]   [Full Text] [Related]  

  • 3. Arkansas cervical cancer program.
    Steinkamp RC; Roman-Lopez J; Kenney JA; Hairston MG; Hylton S; Hammett WN; Marsh S; Becton P; Collier S
    J Ark Med Soc; 1980 Jan; 76(1):312-22. PubMed ID: 6444400
    [No Abstract]   [Full Text] [Related]  

  • 4. Cervical cancer screening: précis and critique of a recent Canadian report.
    Chiavetta J; Leader SR
    Med J Aust; 1977 Jan 1-8; 1(1-2):23-8. PubMed ID: 840075
    [No Abstract]   [Full Text] [Related]  

  • 5. Cervical cytology in Greenland and occurrence of cervical carcinoma, carcinoma in situ, and dysplasia. Extent and impact of uncoordinated screening activity 1976-1985.
    Højgaard Nielsen N; Jensen H; Hansen PK
    Arctic Med Res; 1988 Oct; 47(4):179-88. PubMed ID: 3214508
    [No Abstract]   [Full Text] [Related]  

  • 6. [Population screening for cervix carcinoma in the city of Rotterdam, 1st round].
    van der Lee-Bijlsma A
    Ned Tijdschr Geneeskd; 1981 Dec; 125(49):2012-5. PubMed ID: 7322220
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [1-year results in the detection of precanceroses and carcinoma of the uterine cervix in Baranja].
    Milojković M; Pajtler M; Makarović Z; Lederer B; Jarcov R
    Jugosl Ginekol Perinatol; 1986; 26(5-6):119-22. PubMed ID: 3657276
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of the age factor in dysplasia and preinvasive and invasive cancer of the cervix uteri in the Parma area].
    Spreafichi F; Gramellini D; Sppreafico L
    Ann Ostet Ginecol Med Perinat; 1976; 97(6):389-97. PubMed ID: 1015753
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevalence of preclinical lesions of the cervix uteri].
    Dabancens A
    Rev Med Chil; 1986 Jun; 114(6):586-90. PubMed ID: 3575955
    [No Abstract]   [Full Text] [Related]  

  • 11. Experience of a continuing mass screening programme. Screening and re-screening for cervical carcinoma in Turku.
    Grönroos M; Tyrkkö J; Järvi O; Rauramo L
    Ann Chir Gynaecol Fenn; 1974; 63(6):470-8. PubMed ID: 4441027
    [No Abstract]   [Full Text] [Related]  

  • 12. The prevalence of abnormal cervical cytology in a group of New Zealand women using contraception: a preliminary report. The New Zealand Contraception and Health Study Group.
    N Z Med J; 1989 Jul; 102(872):369-71. PubMed ID: 2797552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervicovaginal cytology in an indigent population. Comparison of results for 1964, 1981 and 1989.
    Costa MJ; Grimes C; Tackett E; Naib ZM
    Acta Cytol; 1991; 35(1):51-6. PubMed ID: 1994635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial screening for cervical carcinoma in Praestø Amt 1972-1975.
    Berget A; Olsen J; Poll P
    Dan Med Bull; 1978 Dec; 25(6):230-2. PubMed ID: 720143
    [No Abstract]   [Full Text] [Related]  

  • 15. Electrocoagulation and the risk of cervical neoplasia.
    La Vecchia C; Franceschi S; Decarli A; Fasoli M; Gentile A; Gritti P
    Obstet Gynecol; 1985 Nov; 66(5):703-7. PubMed ID: 4058829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in abnormal cervical cytology.
    Heyerdahl-O'Dowd TD
    Ir Med J; 1982 Nov; 75(11):419-22. PubMed ID: 7174261
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies of screening, detection and mortality rates in mass screening for uterine cervical cancer in Shimane prefecture].
    Takahashi K; Moriyama M; Takamiya O; Shibukawa T; Iwanari O; Matsunaga I; Kitao M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):377-82. PubMed ID: 3981047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cervical dysplasia].
    Tabachnik BI; Nikitina MA
    Vopr Onkol; 1984; 30(3):21-8. PubMed ID: 6710945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears.
    van Oortmarssen GJ; Habbema JD
    Int J Epidemiol; 1995 Apr; 24(2):300-7. PubMed ID: 7635589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience in screening for cervical cancer in rural areas of Barsi Tehsil (Maharashtra).
    Nene BM; Jayant K; Malvi SG; Dale PS; Deshpande R
    Indian J Cancer; 1994 Mar; 31(1):34-40. PubMed ID: 8063335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.